Apart from the original RSU1 protein, another 29 kDa isoform (namely, RSU1-X1, with NCBI Reference sequence: XM_005252552.4) produced by alternative splicing has been reported to be present in more aggressive gliomas [47] and breast cancer cells [48]. This evidence concerns the gene RSU1 and central nervous system cancer.